|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.320 USD | +0.87% |
|
+0.87% | +28.89% |
| 05-13 | Protalix BioTherapeutics, Inc., Q1 2026 Earnings Call, May 13, 2026 | |
| 05-13 | Protalix BioTherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.87% | +0.87% | +18.37% | +7.91% | +28.89% | +50.65% | +26.09% | +28.89% | -64.47% | 187M | |
| +1.86% | +0.48% | +12.53% | +29.75% | +12.96% | +55.50% | +163.08% | +418.85% | +1,437.57% | 1,082B | |
| +3.57% | +3.29% | +17.83% | +8.23% | +27.10% | +68.60% | +61.03% | +55.66% | +116.87% | 633B | |
| +3.86% | +1.64% | +9.60% | +7.39% | +4.05% | +32.57% | +24.89% | -2.30% | +33.03% | 339B | |
| -0.56% | +0.96% | +9.43% | -5.62% | +4.83% | +41.67% | +39.35% | +64.67% | +221.07% | 301B | |
| -0.08% | +1.30% | +12.68% | +3.83% | +16.72% | +32.15% | +44.48% | +51.35% | +59.01% | 292B | |
| -1.54% | +2.81% | +20.27% | +37.99% | +0.51% | -25.35% | -39.61% | +23.27% | +79.86% | 225B | |
| +3.55% | +4.41% | +10.62% | +7.53% | +14.31% | +25.45% | +66.28% | +50.44% | +142.51% | 202B | |
| +4.21% | +2.65% | +1.77% | -6.04% | +6.95% | +17.47% | +71.11% | +89.42% | +54.69% | 163B | |
| +1.84% | +0.12% | -4.03% | -14.12% | -2.33% | -4.18% | -33.64% | -38.79% | -31.63% | 139B | |
| +6.03% | +7.47% | +23.28% | +20.36% | +16.47% | +14.89% | +51.92% | +163.31% | +501.82% | 134B | |
| +2.99% | +1.06% | +6.23% | -2.47% | +7.77% | +23.89% | -9.78% | -13.17% | -21.21% | 119B | |
| +0.55% | +1.61% | +8.83% | -6.02% | +10.44% | +44.55% | +45.32% | +12.12% | +0.75% | 107B | |
| +0.74% | +0.99% | +3.11% | -8.20% | -8.35% | -8.08% | -22.85% | -13.75% | +1.05% | 103B | |
| +2.99% | +2.80% | +2.95% | -12.95% | -7.29% | +8.61% | +85.31% | +73.68% | +514.64% | 75.9B | |
| -.--% | +1.73% | - | - | - | - | - | - | - | 63.66B | |
| 0.00% | +13.53% | +53.78% | +34.42% | +44.18% | +104.84% | +5.52% | +3.67% | -41.16% | 59.99B | |
| +1.79% | +11.88% | +15.36% | -3.42% | -8.59% | +3.77% | +14.97% | -18.62% | +264.22% | 52.06B | |
| +1.61% | +5.35% | +12.87% | -7.64% | +10.84% | +21.16% | +17.86% | +42.79% | +20.75% | 51.79B | |
| +1.08% | +4.59% | +13.42% | -2.31% | -2.80% | -2.36% | +13.58% | - | - | 42.46B | |
| Average | +1.77% | +4.25% | +13.10% | +4.67% | +9.30% | +26.62% | +32.89% | +55.08% | +182.74% | 209.3B | |
| Weighted average by Cap. | +2.02% | +5.16% | +12.54% | +11.60% | +11.69% | +37.63% | +67.25% | +140.75% | +463.95% |
- Stock Market
- Stocks
- PLX Stock
- Sector Protalix BioTherapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
